Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Cytek Biosciences Inc
NASDAQ:CTKB
Cytek Biosciences Inc
NASDAQ:CTKB
Price:
5.83
USD
7.96%
Market Closed
Market Cap:
$757.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
CTKB Price Forecast
Based on 6 analysts
Based on 6 analysts
-13% Downside
from
$5.83
today
Cytek Biosciences Inc (CTKB)’s 12-month stock price forecast through November 2027 has a consensus target of $5.1, implying 13% downside. The forecast is based on price targets from 6 Wall Street analysts.
CTKB Analyst Rating
Based on 3 analysts
Based on 3 analysts
Analysts rate CTKB Buy, with 2 of 3 recommending Buy or Strong buy.
Cytek Biosciences Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CTKB's stock price target?
Price Target
5.1
USD
5.1
USD
According to Wall Street analysts, the average 1-year price target for CTKB is 5.1 USD with a low forecast of 4.8 USD and a high forecast of 7.88 USD.
What is the Revenue forecast for Cytek Biosciences Inc?
Projected CAGR
7%
7%
Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Cytek Biosciences Inc?
Projected CAGR
10%
10%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 10%.
